Tehami Dermatology

    Antifungal agents

    Choosing between topical and systemic treatment, and matching the agent to the organism and the site.

    Updated: 2026-09-12

    Written for clinicians and medical students

    This section is a teaching reference for doctors, residents and medical students. It is not patient guidance and not a substitute for clinical examination, and it must not be used for self treatment.

    Agents

    • Allylamines such as terbinafine: fungicidal against dermatophytes, first choice for skin and nail dermatophytosis.
    • Azoles such as itraconazole and fluconazole: broader, covering yeasts, useful in candidiasis and pityriasis versicolor.
    • Griseofulvin: still used in pediatric tinea capitis, particularly Microsporum infection.
    • Topical ciclopirox and amorolfine lacquers: limited efficacy in nail disease as monotherapy.

    Safety and interactions

    • Itraconazole is a strong CYP3A4 inhibitor: review statins, calcium channel blockers and many other drugs before prescribing.
    • Check liver function before prolonged systemic courses and in patients with liver disease or on multiple drugs.
    • Treatment failure usually means wrong diagnosis, reinfection or inadequate duration before it means resistance, although resistant dermatophytosis is a growing regional problem [1].

    Sources

    1. [1] Terbinafine resistant dermatophytosis, PubMed
    2. [2] DermNet, antifungal medications

    By continuing to use this website, you accept our collection of the information necessary to provide our services. See our Privacy Policy.